The Pharmacy Times® Retail Clinical Role section is a comprehensive resource for clinical news and expert insights on issues pertaining to retail, community, and independent pharmacists.
May 16th 2025
Aficamten, a cardiac myosin inhibitor, gains FDA approval, offering hope for improved cardiovascular health in patients with obstructive hypertrophic cardiomyopathy.
Practice Pearls from the 2018 Clostridium Difficile Treatment Guidelines
March 6th 2018The IDSA and SHEA have made a recent update to the previously published practice guidelines for CDI. While many of the recommendations remain the same, there are a few key changes that the update has addressed.
Read More
FDA Advisory Committee Discusses 2018-2019 Flu Vaccine Strains
March 4th 2018WHO officials noted that “recent A(H3N2) viruses were better inhibited by ferret antisera raised against the egg-propagated reference virus A/Singapore/INFIMH-16-0019/2016 compared to ferret antisera raised against other recent egg-propagated A(H3N2) viruses.”
Read More